Abstract
Docosahexaenoeic acid (DHA, 22:6 n-3) is an omega-3 polyunsaturated fatty acid that is found in fish oil and exerts cytotoxic effect on a variety of cell lines. The molecular target, responsible for mediating this effect of DHA, still remains unknown. In this report, we presented experimental evidences for the role of PPAR-γ in conveying the cytotoxic effect of DHA. We showed that DHA induces apoptosis in Reh and Ramos cells and apoptotic effect of DHA is inhibited by the PPAR-γ antagonist GW9662, indicating that PPAR-γ functions as the mediator of the apoptotic effect of DHA. Furthermore, our result showed that DHA induces the PPAR-γ protein levels in both Reh and Ramos cells. Interestingly, DHA was found to induce the expression of p53 protein in Reh cells in a PPAR-γ-dependent manner. The up-regulation of p53 protein by DHA kinetically correlated with the activation of caspase 9, caspase 3, and induction of apoptosis, suggesting a role for p53 in DHA-mediated apoptosis in Reh cells. Taken together, these findings suggest a new signaling pathway, DHA-PPAR-γ-p53, in mediating the apoptotic effect of DHA in Reh cells.
Similar content being viewed by others
References
Blot WJ, Lanier A, Fraumeni JR et al (1975) Cancer mortality among Alaskan natives. J Natl Cancer Inst 55:547–554
Nielsen NH, Hansen JP (1980) Breast cancer in Greenland-selected epidemiological, clinical, and histological features. J Cancer Res Clin Oncol 98:287–299
Reddy BS, Burill C, Rigotty J (1991) Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1551:487–491
Hudson EA, Tisdale MJ (1994) Comparison of the effectiveness of eicosapentaenoic acid administered as either the free acid or ethyl ester as an anticachectic and antitumour agent. Prostaglandins Leukot Essent Fatty Acids 51:141–145
Begin ME, Ells G, Das UN, Horrobin DF (1986) Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 77:1053–1062
Calviello G, Palozza P, Piccioni E et al (1998) Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats effects on proliferation and apoptosis. Int J Cancer 275:699–705
Siddiqui RA, Jenski LJ, Harvey KA et al (2003) Cell-cycle arrest in Jurkat leukaemic cells a possible role for docosahexaenoic acid. Biochem J 5371:621–629
Finstad HS, Dyrendal H, Myhrstad MC et al (2000) Uptake and activation of eicosapentaenoic acid are related to accumulation of triacylglycerol in Ramos cells dying from apoptosis. J Lipid Res 41:554–563
Ding WQ, Vaught JL, Yamauchi H et al (2004) Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity the potential importance of down-regulation of superoxide dismutase 1 expression. Mol Cancer Ther 3:1109–1117
Obata T, Nagakura T, Masaki T et al (1991) Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy 29:1129–1135
Hamid R, Singh J, Reddy RS et al (1999) Inhibition by dietary menhaden oil of cyclooxygenase-1 and -2 in N-nitrosomethylurea-induced rat mammary tumors. Int J Oncol 14:523–528
Chamras H, Ardashian A, Heber D et al (2002) Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 13:711–716
Narayanan BA, Narayanan NK, Reddy BS et al (2001) Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 19:1255–1262
Chiu LC, Wong EY, Ooi VE (2004) Docosahexaenoic acid from a cultured microalga inhibits cell growth and induces apoptosis by upregulating Bax/Bcl-2 ratio in human breast carcinoma MCF-7 cells. Ann N Y Acad Sci 25:734–744
Denys A, Hichami A, Akhan N (2005) n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J Lipid Res 46:752–758
Zhao G, Etherton TD, Martin KR et al (2006) Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 336:909–917
Schoonjans K, Staels B, Auwerx J (1996) The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 26130:93–109
Boitier E, Gautier JC, Roberts R (2003) Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models relevance for human health and disease. Comp Hepatol 312: 3
Chawla A, Repa JJ, Evans RM et al (2001) Nuclear receptors and lipid physiology opening the X-files. Science 30294:1866–1870
Padilla J, Kaur K, Cao HJ et al (2000) Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. J Immunol 15165:6941–6948
Wakino S, Kintscher U, Liu Z et al (2001) Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase C delta pathway in vascular smooth muscle cells. J Biol Chem 276:47650–47657
Fan YY, Spencer TE, Wang N et al (2003) Chemopreventive n-3 fatty acids activate RXR alpha in colonocytes. Carcinogenesis 24:1541–1548
Fujimura S, Suzumiya J, Nakamura K et al (1998) Effects of troglitazone on the growth and differentiation of hematopoietic cell lines. Int J Oncol 13:1263–1267
Konopleva M, Andreeff M (2002) Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies. Curr Opin Hematol 9:294–302
Padilla J, Leung E, Phipps R.P (2002) Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin Immunol 103:22–33
Rosen A, Casciola-Rosen L (1997) Macromolecular substrates for the ICE-like proteases during apoptosis. J Cell Biochem 64:50–54
Anel A, Naval J, Desportes P et al (1992) Increased cytotoxicity of polyunsaturated fatty acids on human tumoral B and T-cell lines compared with normal lymphocytes. Leukemia 6:680–688
Heimli H, Giske C, Naderi S et al (2002) Eicosapentaenoic acid promotes apoptosis in Ramos cells via activation of caspase-3 and -9. Lipids 37:797–802
Finstad HS, Myhrstad MC, Heimli H et al (1998) Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids. Leukemia 12:921–929
Leesnitzer LM, Parks DJ, Bledsoe RK et al (2002) Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41:6640–6650
Yu C, Chen L, Luo H et al (2004) Binding analyses between Human PPARgamma-LBD and ligands. Eur J Biochem 271:386–397
Lee H, Finck BN, Jones LA et al(2006) Synthesis and evaluation of a bromine-76-labeled PPARgamma antagonist 2-bromo-5-nitro-N-phenylbenzamide. Nucl Med Biol 33:847–854
Hampel JK, Brownrigg LM, Vignarajah D et al (2006) Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells. Prostaglandins Leukot Essent Fatty Acids 74:283–293
Lorente-Cebrian S, Perez-Matute P, Martinez JA et al (2006) Effects of eicosapentaenoic acid (EPA) on adiponectin gene expression and secretion in primary cultured rat adipocytes. J Physiol Biochem 62:61–69
Tsujita-Kyutoku M, Yuri T, Danbara N et al (2004) Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: potential mechanisms of action. Breast Cancer Res 6: R291–R299
Narayanan NK, Narayanan BA, Bosland M et al (2006) Docosahexaenoic acid in combination with celecoxib modulates HSP70 and p53 proteins in prostate cancer cells. Int J Cancer 119:1586–1598
Li M, Lee TW, Yim AP et al (2006) Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells. J Cell Physiol 209:428–438
Lovekamp-Swan T, Chaffin CL (2005) The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells. Mol Cell Endocrinol 233:15–24
Chipuk JE, Green DR (2006) Dissecting p53-dependent apoptosis. Cell Death Differ 13:994–1002
Acknowledgments
We are grateful to Professor Heidi Keil Blomhoff, Department of Biochemistry, Institute Group of Basic Medical Sciences, University of Oslo-Norway for allowing us to carry out most of this work in her laboratory. We also thank Dr Biserka Relic, Department of Rheumatology, University of Liege, Belgium for providing the PPAR-γ antibody.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zand, H., Rhimipour, A., Bakhshayesh, M. et al. Involvement of PPAR-γ and p53 in DHA-induced apoptosis in Reh cells. Mol Cell Biochem 304, 71–77 (2007). https://doi.org/10.1007/s11010-007-9487-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-007-9487-5